Clovis Oncology
CLVS
#10297
Rank
C$16.26 M
Marketcap
C$0.11
Share price
0.00%
Change (1 day)
-95.15%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -C$0.29 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are C$0.13 Billion. In 2021 the company made an earning of -C$0.33 Billion, an increase over its 2020 earnings that were of -C$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$0.29 Billion-12.67%
2021 -C$0.33 Billion-32.64%
2020 -C$0.48 Billion-9.06%
2019 -C$0.53 Billion7.49%
2018 -C$0.49 Billion4.42%
2017 -C$0.47 Billion-8.83%
2016 -C$0.52 Billion-0.4%
2015 -C$0.52 Billion140.82%
2014 -C$0.22 Billion86.64%
2013 -C$0.12 Billion19.53%
2012 -C$96.06 Million
2010 -C$36.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
C$0.93 B-412.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$18.08 B-6,121.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$16.37 B-5,551.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.75 B-15,001.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.29 B-863.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.08 B-10,451.05%๐Ÿ‡บ๐Ÿ‡ธ USA